WHO: Therapeutic trial results against COVID-19 expected in 3 weeks
Updated 14:56, 21-Feb-2020
CGTN

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

Error loading player: No playable sources found
00:28

The World Health Organization (WHO) said Thursday that preliminary results from clinical trials of therapeutics against COVID-19 are expected in three weeks. 

"We're also looking forward to results from two clinical trials of therapeutics prioritized by the WHO R&D Blueprint," WHO Director-General Tedros Adhanom Ghebreyesus said at a daily briefing. 

One of the trials he referred to is the combination of two drugs for HIV, Lopinavir and Ritonavir, while the other is testing an antiviral called remdesivir. "We expect preliminary results in three weeks," he added. 

Remdesivir is a drug developed by U.S. pharmaceutical company Gilead Sciences. It has shown good antiviral activity against SARS and MERS coronavirus in previous cell and animal experiments. 

It has also shown fairly good antiviral activity against the COVID-19 at the cellular level. A randomized, double-blind, placebo-controlled clinical trial of remdesivir started on February 6 in several hospitals in the central Chinese city of Wuhan, and the trial will last until the end of April. 

A study published in 2004 showed the anti-HIV drug combination of Lopinavir and Ritonavir has "substantial clinical benefit" when given to patients who had SARS. The Wuhan Jinyintan Hospital, where the first 41 known patients were treated, has already launched a randomized, controlled trial of the anti-HIV drug combination, according to a report by Chinese researchers in the Lancet medical journal late last month. 

The third version of COVID-19 treatment guidelines published by China's National Health Commission suggested that taking two Lopinavir/Ritonavir pills and inhaling a dose of nebulized alpha-interferon twice a day could benefit patients.

(Top image via VCG)

Source(s): Xinhua News Agency
TOP NEWS
China says it opposes any tariff deals at expense of own interests
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

China

05:25, 21-Apr-2025

China, Azerbaijan eye broad prospects for cooperation
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Politics

12:41, 21-Apr-2025

China, Indonesia vow higher-level ties, deepened security cooperation
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Politics

12:58, 21-Apr-2025